Solara Active Pharma Sciences Limited (SOLARA) — Cash Flow-to-Debt Ratio
Solara Active Pharma Sciences Limited (SOLARA) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of Rs740.70 Million could theoretically repay 0% of its total liabilities (Rs10.36 Billion) in one year. See SOLARA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Solara Active Pharma Sciences Limited Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Solara Active Pharma Sciences Limited across 9 annual periods. For the full cash flow conversion analysis, see Solara Active Pharma Sciences Limited cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Solara Active Pharma Sciences Limited (2017–2025)
Year-by-year debt coverage analysis for Solara Active Pharma Sciences Limited. Check SOLARA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs2.13 Billion | Rs11.35 Billion | ▲ +143.6% |
| 2024 | 0.08x | Rs1.09 Billion | Rs14.14 Billion | ▼ -31.2% |
| 2023 | 0.11x | Rs1.56 Billion | Rs13.97 Billion | ▲ +165.5% |
| 2022 | -0.17x | Rs-2.42 Billion | Rs14.18 Billion | ▼ -212.1% |
| 2021 | 0.15x | Rs1.55 Billion | Rs10.21 Billion | ▼ -33.7% |
| 2020 | 0.23x | Rs2.44 Billion | Rs10.63 Billion | ▲ +43.6% |
| 2019 | 0.16x | Rs1.60 Billion | Rs10.00 Billion | ▲ +242.1% |
| 2018 | 0.05x | Rs492.23 Million | Rs10.53 Billion | ▼ -100.0% |
| 2017 | 14916.06x | Rs492.23 Million | Rs33.00K | — |